NASDAQ:MRNA • US60770K1079
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.94B | 3.24B | 6.85B | 19.26B | 18.47B | |||
| Cost Of Goods | 868.00M | 969.00M | 2.49B | 5.42B | 2.62B | |||
| Gross Profit | 1.08B | 2.27B | 4.36B | 13.85B | 15.85B | |||
| Operating Expenses | 4.15B | 5.72B | 6.39B | 4.43B | 2.56B | |||
| Research and Development | 3.13B | 4.54B | 4.84B | 3.29B | 1.99B | |||
| Selling, General, and Administrative Expenses | 1.02B | 1.17B | 1.55B | 1.13B | 567.00M | |||
| Operating Income | -3.07B | -3.45B | -2.04B | 9.42B | 13.30B | |||
| Interest Income/Expense | 314.00M | 345.00M | 311.00M | 151.00M | 1.00M | |||
| Other Income/Expense | -8.00M | -7.00M | -14.00M | 4.00M | -12.00M | |||
| Non Recurring Items | N/A | -495.00M | -2.20B | N/A | N/A | |||
| Income Before Taxes | -2.77B | -3.61B | -3.94B | 9.57B | 13.29B | |||
| Income Tax | 54.00M | -46.00M | 772.00M | 1.21B | 1.08B | |||
| Net Income | -2.82B | -3.56B | -4.71B | 8.36B | 12.20B | |||
| EBITDA | -2.86B | -3.26B | -1.42B | 9.77B | 13.53B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -7.25 | -9.27 | -12.34 | 20.10 | 28.31 | |||
| Non GAAP EPS | -7.27 | -9.28 | -12.41 | 19.96 | 28.29 | |||
| Statistics | ||||||||
| Gross Profit Margin | 55.35% | 70.06% | 63.60% | 71.88% | 85.83% | |||
| Profit Margin | -145.16% | -110.04% | -68.84% | 43.41% | 66.06% | |||
| Operating Profit Margin | -158.13% | -106.61% | -29.78% | 48.90% | 71.98% | |||
All data in USD